ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3234

Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis

Renise Ayearst1, Daniel Pereira1, Charles Lynde2, Holly Etchegary3 and Vinod Chandran1, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Memorial University of Newfoundland, St.John's, NF, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Education, medical, psoriasis, qualitative and spondylarthritis, Referrals

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: ARHP IV: Clinical Practice and Patient Care

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The current system of referral by Canadian dermatologists of patients who may have psoriatic arthritis (PsA) to rheumatologists is suboptimal. Hypothesizing that knowledge level, attitude and confidence in being able to refer appropriately impacts the ability of dermatologists to refer patients who may have PsA to a rheumatologist, we aimed to define their current awareness of, and practices relating to, the diagnosis and referral of PsA.

Methods: Based on recommendations from our advisory group comprising rheumatologists, dermatologists, methodologists and patient-partners, questions for structured interviews and focus groups with practicing dermatologists were developed. Dermatologists from across Canada at different stages of their career were recruited via electronic mail. Telephone or face-to-face interviews and focus groups were conducted by trained research associates. The interviews and focus groups were recorded, transcribed, and analyzed by 2 experts and key themes identified.

Results: 8 interviews and 2 focus groups involving a total of 20 dermatologists in community practice (10 males, mean years in practice 18.4) were conducted and data saturation reached. The following themes were identified- (1) Self-perceived knowledge of psoriasis and associated co-morbidities was fairly high [mean of 8.5 (out of 10) across the interviews and 7.1 across focus groups]. (2) The number of patients with psoriasis seen was quite variable, 30-50 weekly on average. Of these, the percentage with PsA or suspected PsA ranged from 5%-50%. (3) Co-morbidities, including PsA, diabetes, obesity, heart disease, depression, metabolic syndrome, and hypertension were consistently mentioned. (4) Red flags noted for PsA included morning stiffness and joint pain. Fewer mentioned nail lesions and joint swelling. (5) All dermatologists recognized the importance of identifying PsA early, both for the patient and for the broader healthcare system. (6) There was a notable divide between their perceived role in screening for PsA and in making the diagnosis. A minority of respondents felt comfortable managing PsA if it was mild without confirmation by a rheumatologist. (7) If arthritis is perceived to be mild, dermatologists perceive an ongoing role in patient management. Other aspects of the healthcare system that affected dermatologists’ perception included the nature of the local healthcare context, access to rheumatologists, and the role of primary care.

Conclusion: This qualitative study shows that dermatologists have high self-perceived knowledge of psoriasis, PsA and its associated comorbidities, and recognize the importance of identifying PsA early. However, the nature of the local healthcare context and access to rheumatologists are significant road blocks to appropriate referral.


Disclosure: R. Ayearst, None; D. Pereira, None; C. Lynde, None; H. Etchegary, None; V. Chandran, None.

To cite this abstract in AMA style:

Ayearst R, Pereira D, Lynde C, Etchegary H, Chandran V. Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/roadblocks-perceived-by-canadian-dermatologists-for-referring-patients-with-suspected-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/roadblocks-perceived-by-canadian-dermatologists-for-referring-patients-with-suspected-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology